Drug Development

To advance new drug candidates into clinical trials and marketing approval, a high-quality preclinical safety program that meets regulatory guidelines and is managed by a team you trust is of paramount importance. IITRI’s experienced study directors work collaboratively with you to design a customized preclinical drug development program that is tailored to the characteristics of your drug candidate and your timeline and follows regulatory guidelines. A high level of quality in preclinical study design and execution is ensured for your pipeline of drug candidates.

IITRI offers all functions of drug development studies at one location, including toxicology, pathology, and bioanalytical, for seamless management of your IND program.